Sweden
Suturion, a Swedish health care and manufacturing startup established in 2018, aims to set a new gold standard for abdominal wall closure and improve surgical outcomes. The company's mission is rooted in addressing the painful and challenging post-operative issues that often arise after open abdominal surgery. Scientific research underscores the significance of adopting the right surgical techniques to minimize complications, including incisional hernias and deep wound infections.
Founded by surgeon Gabriel Börner, medtech engineer Mats O. Christensson, and LU Holding AB, Suturion has diligently pursued patent applications, market analysis, and pre-clinical research to support its innovative approach. The startup's dedication to evidence-based surgical techniques and commitment to assisting clinicians align with best practice principles, positioning it as a pioneer in preventative care within the surgical domain.
The recent kr15.00M Venture Round investment on 30th July 2022, led by Almi Invest and LU Innovation, demonstrates the industry's acknowledgment and support for Suturion's groundbreaking advancements in abdominal wall closure. Furthermore, the finalization of a clinical trial in 2024 marks a pivotal milestone as the company progresses towards the regulatory pathway for CE and FDA approval.
